Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

GameStop’s Earnings Don’t Justify Its Price, But Investors Don’t Care

By Mark R. Hake, CFA
GameStop's earnings don't justify the rise in GME stock, but investors don't care. GME stock is not worth its present price, even after its most recent capital raise, but investors still think it should rise.

Take Your 3D-Printed Ball to a Different Court and Move On From 3D Systems

By Luke Lango and the InvestorPlace Research Staff
Earlier in May, we recommended DDD stock. If you had invested at that time, you'd be sitting pretty with a 75% share price increase. That time has since passed, and it's time to move on to other players in the space.

3 Pros, 3 Cons of Ideanomics’ Electric Tractor Argument

By Josh Enomoto, InvestorPlace Contributor
While IDEX stock doesn’t lack for popularity, prospective buyers should perform their due diligence on Ideanomics before making a move.

There’s Not Much on the Horizon to Recharge Quantumscape Stock

By Thomas Niel, InvestorPlace Contributor
It's holding steady today but instead of rebounding, lukewarm sentiment and the public debut of a rival could send QS stock lower.

MicroVision Simply Is Not What It Was Billed To Be

By Alex Sirois, InvestorPlace Contributor
MVIS stock isn't going to fulfill promises for pundits who want it in electric vehicles, or meme traders who want a short squeeze.

Churchill Capital’s Premium Is Rich But It’s Not Crazy

By Josh Enomoto, InvestorPlace Contributor
While CCIV stock, which will eventually become Lucid Motors’ equity unit, seems outrageously rich, there’s some credibility here.

DoorDash Stock Is Priced for Perfection Here, but Watch for Dips

By Faizan Farooque, InvestorPlace Contributor
DASH stock is trading at prodigious price multiples, especially with people starting to return to sit-down restaurants as restrictions ease.

Revenue Crush Makes Ayr Wellness a Prime Cannabis Pick

By David Moadel, InvestorPlace Contributor
Ayr Wellness is expanding quickly, yet AYRWF stock doesn't truly reflect the company's exciting growth story - but that could change soon.

Bionano Genomics: Did Reddit Squirrels Find a Nut?

By Dana Blankenhorn, InvestorPlace Contributor
Bionano Genomics offers a system called Saphyr that does optical genetic sequencing. If the technique floods the market, it could be a winner.

Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships

By Louis Navellier and the InvestorPlace Research Staff
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest.

Valuation Remains A Concern For Lucid Motors

By Faisal Humayun, InvestorPlace Contributor
CCIV stock looks expensive even after a significant correction from highs. The company's revenue projection seems too optimistic as competition increases.

Microsoft Stock Is Boss, But it Would Be Even Better Lower

By Nicolas Chahine, InvestorPlace Contributor
MSFT stock hasn't made a false move in almost three years. The risk now lies in the equity market. New investors should be patient now.

With Merger Complete, Here’s Tilray’s Roadmap to Profitability

By Ian Bezek, InvestorPlace Contributor
TLRY stock soared and crashed due to a misguided short squeeze attempt. However, Tilray now has a real shot at turning the business around.

7 Stocks to Watch If Climate Risk Disclosures Come to Pass

By Bret Kenwell, InvestorPlace Contributor
We're not here to debate climate change. Instead, we're here to look at which companies could be impacted. Here are seven stocks to watch.

If You’re Buying The Asensus Surgical Stock Rebound, Watch Out

By Thomas Niel, InvestorPlace Contributor
For those looking for short-term trades, this could still end up being a profitable opportunity. But, considering its history of disappointments, don't be surprised if sentiment for ASXC stock once again turns on a dime.

QuantumScape Stock Is Purely Speculative

By Dana Blankenhorn, InvestorPlace Contributor
No one knows whether Quantumscape can produce solid lithium-ion batteries without dendrites so QS stock is speculative.

ContextLogic Has More Than Just Meme Status to Power Gains

By Ian Bezek, InvestorPlace Contributor
ContextLogic has risen to prominence as a meme stock. However, there's more to WISH stock's appeal than just social media hype.

Did You Miss Your Chance to Buy GE Stock?

By Bret Kenwell, InvestorPlace Contributor
General Electric has been trading much better over the past few quarters, but many investors feel they've missed GE stock. Is it true?

Analyst Says Bionano Genomics Has 26% Upside: Should You Buy?

By Will Ashworth, InvestorPlace Contributor
BTIG analyst Sung Ji Nam recently initiated coverage of Bionano Genomics with a buy rating and a price target of $10. Is BNGO stock a buy?     
Load More Articles